These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 673023)

  • 1. Comparison of the pharmacokinetics of digoxin and dihydrodigoxin in cats in single-dose studies.
    Heinz N; Flasch H
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jun; 303(2):181-7. PubMed ID: 673023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development and application of a radioimmunoassay for dihydrodigoxin, a digoxin metabolite.
    Butler VP; Tse-Eng D; Lindenbraum J; Kalman SM; Preibisz JJ; Rund DG; Wissel PS
    J Pharmacol Exp Ther; 1982 Apr; 221(1):123-31. PubMed ID: 7062278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The measurement of urinary digoxin and dihydrodigoxin by radioimmunoassay and by mass spectroscopy.
    Greenwood H; Snedden W; Hayward RP; Landon J
    Clin Chim Acta; 1975 Jul; 62(2):213-24. PubMed ID: 1170963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased metabolism to dihydrodigoxin after intake of a microencapsulated formulation of digoxin.
    Magnusson JO; Bergdahl B; Bogentoft C; Gustafsson S; Jonsson UE
    Eur J Clin Pharmacol; 1984; 27(2):197-202. PubMed ID: 6499898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of tritiated digoxin and metabolites in urine by liquid chromatography.
    Eriksson BM; Tekenbergs L; Magnusson JO; Molin L
    J Chromatogr; 1981 May; 223(2):401-8. PubMed ID: 7251795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of digoxin to 20R-dihydrodigoxin by cultures of Eubacterium lentum.
    Robertson LW; Chandrasekaran A; Reuning RH; Hui J; Rawal BD
    Appl Environ Microbiol; 1986 Jun; 51(6):1300-3. PubMed ID: 3729400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotransformation and elimination of digoxin with normal and minimal renal function.
    Gault MH; Sugden D; Maloney C; Ahmed M; Tweeddale M
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):499-513. PubMed ID: 436354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of beta-methyldigoxin in healthy humans I: intravenous studies.
    Hinderling PH; Garrett ER; Wester RD
    J Pharm Sci; 1977 Feb; 66(2):242-53. PubMed ID: 839422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of digoxin in the rat.
    Harrison LI; Gibaldi M
    Drug Metab Dispos; 1976; 4(1):88-93. PubMed ID: 3407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for presence of a reduced form of digoxin-like immunoreactive factor (dihydro-DLIF) in mammalian tissues.
    Qazzaz HM; Jortani SA; Poole JM; Valdes R
    Clin Chem; 1996 Jul; 42(7):1092-9. PubMed ID: 8674194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin and metabolites in urine: a derivatization--high-performance liquid chromatographic method capable of quantitating individual epimers of dihydrodigoxin.
    Bockbrader HN; Reuning RH
    J Chromatogr; 1984 Sep; 310(1):85-95. PubMed ID: 6501524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of digoxin and absorption site.
    Magnusson JO; Bergdahl B; Bogentoft C; Jonsson UE
    Br J Clin Pharmacol; 1982 Aug; 14(2):284-5. PubMed ID: 7104181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of digoxin.
    Iisalo E
    Clin Pharmacokinet; 1977; 2(1):1-16. PubMed ID: 322907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of digoxin in the turkey and comparison with other species.
    Park E; Einzig S; Staley NA; Noren GR
    J Pharmacokinet Biopharm; 1981 Jun; 9(3):357-66. PubMed ID: 7288595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of the digoxin radioimmunoassay with respect to dihydrodigoxin.
    Kramer WG; Bathala MS; Reuning RH
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):83-8. PubMed ID: 935656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of [20R]-dihydrodigoxin from digoxin in humans.
    Reuning RH; Shepard TA; Morrison BE; Bockbrader HN
    Drug Metab Dispos; 1985; 13(1):51-7. PubMed ID: 2858377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary excretion studies with digoxin in man.
    Klotz U; Antonin KH
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):332-4. PubMed ID: 892949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of digoxin-specific antibody fragments on digoxin disposition in the rat.
    Johnston PC; Stevenson IH; Hewick DS
    Biochem Pharmacol; 1987 Jul; 36(13):2215-20. PubMed ID: 3606637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dihydrogenated metabolites of digoxin: clinical importance and identification (author's transl)].
    Peters U; Kalman SM
    Z Kardiol; 1978 May; 67(5):342-5. PubMed ID: 654418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the pharmacokinetics and the metabolism of gitoxin in the guinea-pig: I. Disposition kinetics following an i.v. bolus of 3H-gitoxin.
    Kadima LN; Lesne M
    Arch Int Pharmacodyn Ther; 1980 May; 245(1):20-41. PubMed ID: 7406600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.